Ссылка
click to show
click to show
US Seeks Bio Risk Protection
The US White House is seeking protection from biological risks associated with AI after cutting a high-profile team. By the end of the Joe Biden administration, the White House had up to 30 biodefense specialists. After cuts and reorganizations, former officials said there were periods when no dedicated staff member was working on the issue. Protection from biological risks of AI involves several actions, including assessing risk throughout the workflow of a trained biologist.
The risk assessment path shows that a model can help design a DNA sequence, a synthetic DNA supplier can check an order, and a laboratory can provide access to equipment and biological samples. Government policy connects these points with rules and agency work. One of these points is the ordering of synthetic DNA. The 2024 framework tied federal funding to sequence and buyer screening: laboratories must purchase DNA, other nucleic acids, and desktop devices for their synthesis from suppliers that comply with these requirements.
A White House directive on May 5, 2025, gave the White House Office of Science and Technology Policy 90 days to review or replace the framework. On July 28, the US Department of Health and Human Services announced a new national policy for oversight of high-risk life sciences research, which prohibits federal funding for certain work that intentionally enhances dangerous properties of pathogens and introduces independent review of certain high-risk research, as reported in The Washington Post.
🔗 Read original →
5 ·